What is Eikon Therapeutics, Inc. 's retained earnings?

Eikon Therapeutics, Inc. (EIKN) reported retained earnings of -$1B in Q1 2026.

What does retained earnings mean?

Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

MYR GroupMYRG

$549.78M+34.7%

Travel + LeisureTNL

$2.45B+3.6%

UnifirstUNF

$2.09B+1.1%

Main Street CapitalMAIN

$485.43M+14.1%

BeldenBDC

$1.45B+18.7%

Cabot CorporationCBT

$1.84B+1.8%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$514.86M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's retained earnings?: Eikon Therapeutics, Inc. (EIKN) reported retained earnings of -$1B in Q1 2026.
What does retained earnings mean?: Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.